Company intelligence / Profile preview

BNH Investment

Seoul, Seoul, South Koreabnhinv.com ↗

Ownership: Private
Development stage: Other

Overview

BNH Investment is a South Korea-based venture capital firm focused on investing in innovative companies within the biotechnology, pharmaceutical, and healthcare sectors. The firm has made at least 58 investments as of early 2025, including recent funding rounds for companies such as CellArk Bio and LabInCube. Its portfolio includes startups developing cell therapies for brain diseases, drug delivery materials, and other advanced health technologies.

Industry: Investors

Partnerships

Co-investments with BonAngels Venture PartnersDevsisters VenturesHB Investment

Beyond the preview

Go deeper on BNH Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BNH Investment.

Explore the full profile